Postoperative pain management: A practical review, part 2

被引:39
作者
Strassels, SA [1 ]
McNicol, E
Suleman, R
机构
[1] Univ Washington, Sch Pharm, Dept Pharm, Seattle, WA 98195 USA
[2] Univ Texas, Coll Pharm, Div Pharm Practice, Austin, TX 78712 USA
[3] Univ Washington, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA
[4] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA
[5] Nova Pharmaceut Corp, Carlsbad, CA USA
[6] Janssen Med Affairs LLC, Reg Med Serv, Carlsbad, CA USA
关键词
dosage; drug use; economics; opiates; pain; pharmacists; rational therapy; surgery; toxicity;
D O I
10.2146/ajhp040490.p2
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Purpose. The pharmacotherapy and assessment of postoperative pain in general pharmacy practice settings are reviewed. Summary. Numerous factors related to all levels of society and the health care system contribute to suboptimal treatment of postoperative pain, despite awareness of this challenge for at least the past 30 years. and the availability of potent analgesics and tools to help clinicians care for persons with postoperative pain. The consequences of acute pain include clinical, economic, and patient-reported outcomes; thus, improving the treatment of postoperative pain has the potential to improve health care from a broad perspective. Opioids remain the cornerstone of treatment of postoperative pain. Multimodal analgesia also has the potential to improve the pharmacotherapy of postoperative pain. In addition to the appropriate use of drugs, it is important that clinicians be comfortable with equianalgesic dosage conversion, helping ensure that analgesic-related adverse effects are minimal, assessing pain and function, and incorporating this information into patient care. Conclusion. Providing optimal management of postoperative pain is a vital goal for all health care providers. There is substantial potential for pharmacists to help meet this goal.
引用
收藏
页码:2019 / 2025
页数:7
相关论文
共 30 条
[1]
[Anonymous], EVIDENCE BASED RESOU
[2]
Cleeland C S., BRIEF PAIN INVENTORY
[3]
Dalton J A, 2001, Pain Manag Nurs, V2, P54, DOI 10.1053/jpmn.2001.23918
[4]
Changing acute pain management to improve patient outcomes: An educational approach [J].
Dalton, JA ;
Blau, W ;
Lindley, C ;
Carlson, J ;
Youngblood, R ;
Greer, SM .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1999, 17 (04) :277-287
[5]
DEVELOPMENT OF THE WISCONSIN BRIEF PAIN QUESTIONNAIRE TO ASSESS PAIN IN CANCER AND OTHER DISEASES [J].
DAUT, RL ;
CLEELAND, CS ;
FLANERY, RC .
PAIN, 1983, 17 (02) :197-210
[6]
FULTON CW, 2001, HOSP PHARM, V36, P1214
[7]
Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain [J].
Goudas, LC ;
Langlade, A ;
Serrie, A ;
Matson, W ;
Milbury, P ;
Thurel, C ;
Sandouk, P ;
Carr, DB .
ANESTHESIA AND ANALGESIA, 1999, 89 (05) :1209-1215
[8]
A systematic review of the peripheral analgesic effects of intraarticular morphine [J].
Gupta, A ;
Bodin, L ;
Holmström, B ;
Berggren, L .
ANESTHESIA AND ANALGESIA, 2001, 93 (03) :761-770
[9]
WHAT IS THE MAXIMUM NUMBER OF LEVELS NEEDED IN PAIN INTENSITY MEASUREMENT [J].
JENSEN, MP ;
TURNER, JA ;
ROMANO, JM .
PAIN, 1994, 58 (03) :387-392
[10]
Jensen MP., 2001, Handbook of pain assessment, V2nd ed, P15